A Trial to Compare Three Methods of Performing Hysterosalpingography
NCT ID: NCT00870935
Last Updated: 2010-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
222 participants
INTERVENTIONAL
2007-08-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to determine whether the choice of the device for performing hysterosalpingography on the basis of the cervix characteristics can reduce the procedure failure rate;
* to determine whether patient medical history is correlated with the degree of pain experienced during the HSG procedure.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The operator will ask the woman to evaluate the degree of pain experienced during the application of the device and the injection of the contrast, after 2, 6 and 24 hours. The degree of pain will be evaluated using the VAS system, an analogue scale rating from 1 to 10.
A nurse will notice the patient's reaction and will evaluate the pain, depending on the movements of the hands and the body and the woman's moaning. Moreover, the assistant will note down the personal data and the history of the patient. The operator will record the objective and subjective difficulty of the performance, using a rating scale from 0 to 9. The length of the procedure, the volume of contrast used, the amount of radiations and the time of exposure of the patient will also be considered.
At the end of HSG both the gynaecologist and the radiologist will express their satisfaction upon the examination with a score from 0 to 10.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Balloon catheter
Hysterosalpingography using intrauterine Balloon catheter
Balloon catheter
Hysterosalpingography is performed using intrauterine balloon catheter
Cervical vacuum cup
Hysterosalpingography using cervical vacuum cup
Cervical vacuum cup
Hysterosalpingography is performed using cervical vacuum cup
Operator choice
Hysterosalpingography is performed using either balloon catheter or cervical vacuum cup on the basis of the operator's choice
Balloon catheter
Hysterosalpingography is performed using intrauterine balloon catheter
Cervical vacuum cup
Hysterosalpingography is performed using cervical vacuum cup
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Balloon catheter
Hysterosalpingography is performed using intrauterine balloon catheter
Cervical vacuum cup
Hysterosalpingography is performed using cervical vacuum cup
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* cervicitis
* genital bleeding
* genital malignancy
25 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Burlo Garofolo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
IRCCS Burlo Garofolo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Ricci, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Burlo Garofolo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Burlo Garofolo
Trieste, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RU02/07
Identifier Type: -
Identifier Source: org_study_id